Inventor · disambiguated record
Simon David Peter Baugh
Also filed as: BAUGH SIMON D P · BAUGH SIMON DAVID PETER
6 granted patents·5 pending applications·19 citations·filing 2001–2022
77Inventor score
Files withUNIV PENNSYLVANIA3AUGERI DAVID JOHN2LEXICON PHARMACEUTICALS INC2UNIV DREXEL2FOX CHASE CHEMCIAL DIVERSITY CENTER INC1
Top patents by PatentIndex Score
11 records- 0184US7825142B2Heterocyclic compounds, compositions comprising them and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2009·Granted Nov 2, 2010·6 cites·10 claims
- 0284US7598280B2Heterocyclic compounds, compositions comprising them and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2008·Granted Oct 6, 2009·6 cites·2 claims
- 0381US9938236B2Antiviral agents against HBV infectionUNIV DREXEL·Filed 2013·Granted Apr 10, 2018·5 cites·19 claims
- 0465US8440652B2MST1 kinase inhibitors and methods of their useAUGERI DAVID JOHN·Filed 2012·Granted May 14, 2013·2 cites·17 claims
- 0556US2025295652A1Inhibitors of Molluscum Contagiosum Infection and Methods Using the SameUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 0650US2024018121A1Novel heteroaromatic compounds exhibiting antifungal activity and their method of useFOX CHASE CHEMCIAL DIVERSITY CENTER INC·Filed 2021·Application pending·0 cites
- 0749US2018230092A1Novel antiviral agents against hbv infectionUNIV DREXEL·Filed 2018·Application pending·0 cites
- 0846US2003134824A1Beta-cyclodextrin dimers and phthalocyanines and uses thereofFiled 2001·Application pending·0 cites
- 0941US2014051681A1Mst1 kinase inhibitors and methods of their useAUGERI DAVID JOHN·Filed 2013·Application pending·0 cites
- 1036US12077527B2Compositions and methods for inhibiting ACSS2UNIV PENNSYLVANIA·Filed 2018·Granted Sep 3, 2024·0 cites·11 claims
- 1135US10112895B2Antivirals against molluscum contagiosum virusUNIV PENNSYLVANIA·Filed 2015·Granted Oct 30, 2018·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Simon David Peter Baugh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →